Complete financial analysis of Safety Shot Inc (SHOT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Safety Shot Inc, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Daiken Corporation (7905.T) Income Statement Analysis – Financial Results
- Ulusoy Elektrik Imalat Taahhüt ve Ticaret A.S. (ULUSE.IS) Income Statement Analysis – Financial Results
- Kia Corporation (000270.KS) Income Statement Analysis – Financial Results
- Sydinvest Mellemlange Obligationer (SYIMOADKK.CO) Income Statement Analysis – Financial Results
- A.P. Møller – Mærsk A/S (0O77.IL) Income Statement Analysis – Financial Results
Safety Shot, Inc. (SHOT)
Industry: Beverages - Non-Alcoholic
Sector: Consumer Defensive
Website: https://safetyshotofficial.com
About Safety Shot, Inc.
Safety Shot, Inc., a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen. The company sells its products through distributors, retailers, and e-commerce websites. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 202.67K | 6.20M | 2.88M | 1.07M | 6.46K | 0.00 |
Cost of Revenue | 277.13K | 5.17M | 2.34M | 624.57K | 18.02K | 0.00 |
Gross Profit | -74.46K | 1.03M | 535.49K | 441.10K | -11.57K | 0.00 |
Gross Profit Ratio | -36.74% | 16.56% | 18.62% | 41.39% | -179.23% | 0.00% |
Research & Development | 100.59K | 1.64M | 1.08M | 308.37K | 108.96K | 99.00K |
General & Administrative | 11.24M | 12.52M | 17.31M | 5.58M | 908.72K | 199.40K |
Selling & Marketing | 566.67K | 84.69K | 522.89K | 82.37K | 74.15K | 60.00K |
SG&A | 12.01M | 12.52M | 17.31M | 5.58M | 908.72K | 259.40K |
Other Expenses | 0.00 | 1.54K | 699.70K | 0.00 | 0.00 | 0.00 |
Operating Expenses | 12.11M | 12.52M | 17.31M | 5.58M | 908.72K | 358.40K |
Cost & Expenses | 12.39M | 17.69M | 19.65M | 6.20M | 926.74K | 358.40K |
Interest Income | 57.34K | 1.72K | 7.32K | 3.04K | 1.38K | 0.00 |
Interest Expense | 171.43K | 1.29M | 1.74M | 116.80K | 6.56K | 0.00 |
Depreciation & Amortization | 215.18K | 93.47K | 187.92K | 161.37K | 920.29K | 358.40K |
EBITDA | -12.19M | -15.29M | -26.18M | -6.01M | -918.91K | 0.00 |
EBITDA Ratio | -6,012.33% | -176.99% | -576.30% | -466.44% | -14,235.55% | 0.00% |
Operating Income | -12.18M | -11.49M | -16.77M | -5.14M | -920.29K | -358.40K |
Operating Income Ratio | -6,011.82% | -185.39% | -583.09% | -481.87% | -14,256.95% | 0.00% |
Total Other Income/Expenses | -2.64M | -3.73M | -11.33M | -1.15M | -5.18K | 0.00 |
Income Before Tax | -14.82M | -15.22M | -28.10M | -6.29M | -925.46K | -358.40K |
Income Before Tax Ratio | -7,313.13% | -245.66% | -976.97% | -590.17% | -14,337.13% | 0.00% |
Income Tax Expense | 0.00 | 1.29M | 1.74M | 116.80K | -170.48K | 0.00 |
Net Income | -15.08M | -15.22M | -28.10M | -6.29M | -925.46K | -358.40K |
Net Income Ratio | -7,442.17% | -245.66% | -976.97% | -590.17% | -14,337.13% | 0.00% |
EPS | -0.48 | -0.69 | -1.69 | -0.59 | -0.12 | -0.12 |
EPS Diluted | -0.49 | -0.69 | -1.69 | -0.59 | -0.12 | -0.11 |
Weighted Avg Shares Out | 31.32M | 22.11M | 16.60M | 10.66M | 7.97M | 2.99M |
Weighted Avg Shares Out (Dil) | 30.88M | 22.11M | 16.60M | 10.66M | 7.97M | 3.36M |
Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims
Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.
Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.
Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking
Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking
Safety Shot Announces Partnership with Digital Growth Platform VENDO
Safety Shot Releases Second Quarter 2024 Results and Corporate Highlights
Safety Shot Announces Powerful Data Analysis From Recent Clinical Trial Confirming Dramatic Reduction of Blood Alcohol Content
Safety Shot to Release On-the-Go Powder Stick Packs of the World's First Alcohol Reducing Product
Safety Shot to Release On-the-Go Powder Stick Packs of the World's First Alcohol Reducing Product
Source: https://incomestatements.info
Category: Stock Reports